Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report
Rengui Zhou,1 Lei Song,1 Wenwen Zhang,1 Lin Shao,2 Xi Li,2 Xiangyong Li1 1Department of Hematology and Oncology, The 904 Hospital of the PLA (Chinese People’s Liberation Army), Wuxi, People’s Republic of China; 2Burning Rock Biotech, Guangzhou, Guangdong, People’s Repub...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2021-04-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/combination-of-osimertinib-and-anlotinib-may-overcome-the-resistance-m-peer-reviewed-fulltext-article-OTT |